Skip to content

Total Revenue at other companies

Johnson & Johnson logo
Johnson & JohnsonJNJ
$24.06B+9.9%
Amgen logo
AmgenAMGN
$8.62B+5.8%
Kymera Therapeutics logo
Kymera TherapeuticsKYMR
$34.37M+55.5%
Protagonist Therapeutics logo
Protagonist TherapeuticsPTGX
$56.37M+99.0%
TG Therapeutics logo
TG TherapeuticsTGTX
$204.92M+69.6%
Biogen logo
BiogenBIIB
$2.48B+1.9%

Segments

By product

See full
License$463K-60.2%

Other financials

Income statement

See full
Operating income-$46.5M-40.3%
Net income-$40.8M-38.4%
EPS (diluted)-$0.85-3.7%

Balance sheet

See full
Cash & equivalents$627.7M+6,105%
Total debt$1.4M-2.3%
Total equity$1.2B+266%
Total assets$1.2B+258%

Cash flow

See full
Operating cash flow-$28.9M-4.4%
CapEx$10.0K-58.3%
Free cash flow-$28.9M-4.4%

Valuation

See full
Market cap$4.51B+662%
Enterprise value$3.88B+565%
P/S1,465.1×+962×

Profitability

See full
Operating margin-4,558.4%-9,354pp
Net margin-4,104.8%-7,304pp
FCF margin-3,561.6%-6,956pp

Returns & leverage

See full
Return on equity-28.6%+3.2pp
Debt / equity0.0×
Current ratio29.3×+13.3×

Where this comes from

Reported directly by Dianthus Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.

The official record: Dianthus Therapeutics’s 10-Q, filed November 5, 2025, on SEC EDGAR. View the filing →

Ask your AI about Dianthus Therapeutics's total revenue.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Dianthus Therapeutics's total revenue?
Dianthus Therapeutics (DNTH) reported total revenue of $396K in Q3 2025.
How has Dianthus Therapeutics's total revenue changed year-over-year?
Dianthus Therapeutics's total revenue decreased by 81.8% year-over-year, from $2.17M to $396K.
What does total revenue mean?
The aggregate of all revenue from the company's operations — the top line from which all profitability metrics are derived.